Retatrutide

Description

Retatrutide is a next-generation triple agonist peptide that acts on the GLP-1, GIP, and glucagon receptors. It is being researched for its potential to support metabolic balance, glucose regulation, and body composition management. As a multi-pathway incretin agonist, Retatrutide shows promise in enhancing energy expenditure and insulin sensitivity while promoting weight control and fat reduction.

Scientific Information:

• Receptor Activity: GIP / GLP-1 / Glucagon receptor agonist

For Research Use Only. Not for Human Consumption